Cargando…

Potential role of autophagy in T-cell survival in polymyositis and dermatomyositis

Peripheral blood T lymphocytopenia has previously been identified in polymyositis/dermatomyositis (PM/DM) patients. Therefore, the present study aimed to examine the potential role of autophagy in peripheral blood T cell survival in PM/DM patients. Transmission electron microscopy was used to detect...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shu, Xiaoming, Chen, Fang, Peng, Qinglin, Lu, Xin, Tian, Xiaolan, Wang, Yan, Wang, Guochun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2017
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5562052/ https://www.ncbi.nlm.nih.gov/pubmed/28586060 http://dx.doi.org/10.3892/mmr.2017.6693

Ejemplares similares

HMGB1 May Be a Biomarker for Predicting the Outcome in Patients with Polymyositis /Dermatomyositis with Interstitial Lung Disease
por: Shu, Xiaoming, et al.
Publicado: (2016)

Factors Predicting Malignancy in Patients with Polymyositis and Dermatomyostis: A Systematic Review and Meta-Analysis
por: Lu, Xin, et al.
Publicado: (2014)

Significant decrease in peripheral regulatory B cells is an immunopathogenic feature of dermatomyositis
por: Li, Wenli, et al.
Publicado: (2016)

Nutrition and Polymyositis and Dermatomyositis
por: Loell, Ingela, et al.
Publicado: (2008)

Clinical characteristics of anti-SAE antibodies in Chinese patients with dermatomyositis in comparison with different patient cohorts
por: Ge, Yongpeng, et al.
Publicado: (2017)

Polymyositis and dermatomyositis – challenges in diagnosis and management
por: Yang, Shu-Han, et al.
Publicado: (2019)

Viral Etiology of Polymyositis/Dermatomyositis
por: DENMAN, A.M.
Publicado: (1988)

Subcutaneous Edema in Polymyositis and Dermatomyositis
por: Yoshimi, Ryusuke, et al.
Publicado: (2023)

Polymyositis and dermatomyositis: Disease spectrum and classification
por: Raychaudhuri, Siba P, et al.
Publicado: (2012)

Dermatomyositis and polymyositis in total hip arthroplasty
por: Rosas, Samuel, et al.
Publicado: (2021)

Specific Autoantibodies and Clinical Phenotypes Correlate with the Aberrant Expression of Immune-Related MicroRNAs in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2019)

Resistin Expression Is Associated With Interstitial Lung Disease in Dermatomyositis
por: Ye, Lifang, et al.
Publicado: (2022)

Polymyositis and dermatomyositis as a risk of developing cancer
por: Jakubaszek, Michał, et al.
Publicado: (2015)

Cardiac involvement in polymyositis and dermatomyositis: diagnostic approaches
por: Trybuch, Agnieszka, et al.
Publicado: (2023)

Adrenomedullin Expression Is Associated With the Severity and Poor Prognosis of Interstitial Lung Disease in Dermatomyositis Patients
por: Ye, Lifang, et al.
Publicado: (2022)

Expression of tumor necrosis factor-like weak inducer of apoptosis and fibroblast growth factor-inducible 14 in patients with polymyositis and dermatomyositis
por: Peng, Qing-Lin, et al.
Publicado: (2014)

Circulating plasma microRNA profiling in patients with polymyositis/dermatomyositis before and after treatment: miRNA may be associated with polymyositis/dermatomyositis
por: Hirai, Takuya, et al.
Publicado: (2018)

Immunoproteasome subunit β5i promotes perifascicular muscle atrophy in dermatomyositis by upregulating RIG-I
por: Zhang, Lu, et al.
Publicado: (2023)

Serum uric acid is independently associated with hypertension in patients with polymyositis and dermatomyositis
por: liu, mei, et al.
Publicado: (2023)

The RIG-I pathway is involved in peripheral T cell lymphopenia in patients with dermatomyositis
por: Zhang, Lu, et al.
Publicado: (2019)

Predictors of survival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine
por: Schiopu, Elena, et al.
Publicado: (2012)

Expansion of circulating peripheral TIGIT+CD226+ CD4 T cells with enhanced effector functions in dermatomyositis
por: Li, Wenli, et al.
Publicado: (2021)

Upregulation of Interleukin 21 and Interleukin 21 Receptor in Patients with Dermatomyositis and Polymyositis
por: Liu, Tao, et al.
Publicado: (2017)

Hyaluronic acid in dermatomyositis and polymyositis: relationship with disease and cutaneous lesions
por: Silva, Marilda Guimarães, et al.
Publicado: (2018)

STROBE: The correlation of Cyr61, CTGF, and VEGF with polymyositis/dermatomyositis
por: Chai, Ke-Xia, et al.
Publicado: (2018)

Identification of hub biomarkers and immune cell infiltration in polymyositis and dermatomyositis
por: Chen, Si, et al.
Publicado: (2022)

Randomized Trial of Tocilizumab in the Treatment of Refractory Adult Polymyositis and Dermatomyositis
por: Oddis, Chester V., et al.
Publicado: (2022)

Cancer risks of dermatomyositis and polymyositis: a nationwide cohort study in Taiwan
por: Chen, Yi-Ju, et al.
Publicado: (2010)

An efficacy analysis of whole-body magnetic resonance imaging in the diagnosis and follow-up of polymyositis and dermatomyositis
por: Huang, Zhen-guo, et al.
Publicado: (2017)

Coadministration of Cyclosporin A with Prednisolone in Acute Interstitial Pneumonia Complicating Polymyositis/Dermatomyositis
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Increased risk of venous thromboembolism associated with polymyositis and dermatomyositis: a meta-analysis
por: Li, Yanqing, et al.
Publicado: (2018)

Expression of TLR2, TLR4, and TLR9 in dermatomyositis and polymyositis
por: Kim, Geun-Tae, et al.
Publicado: (2009)

The predictive prognostic factors for polymyositis/dermatomyositis-associated interstitial lung disease
por: Sugiyama, Yumiko, et al.
Publicado: (2018)

Epilepsy as a Comorbidity in Polymyositis and Dermatomyositis—A Cross-Sectional Study
por: Nissan, Ella, et al.
Publicado: (2021)

Supervised Physical Therapy and Polymyositis/Dermatomyositis—A Systematic Review of the Literature
por: Corrado, Bruno, et al.
Publicado: (2020)

Clinical Features of Dermatomyositis/Polymyositis with Anti-MDA5 Antibody Positivity
por: Chen, Qiuhe, et al.
Publicado: (2022)

Clinical and Radiological Features of Interstitial Lung Diseases Associated with Polymyositis and Dermatomyositis
por: Palmucci, Stefano, et al.
Publicado: (2022)

Dermatomyositis and Polymyositis in the Intensive Care Unit: A Single-Center Retrospective Cohort Study of 102 Patients
por: Peng, Jin-Min, et al.
Publicado: (2016)

Soluble IL-2 Receptor in Dermatomyositis: Its Associations with Skin Ulcers and Disease Activity
por: He, Linrong, et al.
Publicado: (2020)

Coadministration of tacrolimus with corticosteroid accelerates recovery in refractory patients with polymyositis/ dermatomyositis: a retrospective study
por: Shimojima, Yasuhiro, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_afda8dhobu2sdvlbned928nn30